General Genomics Inc.
AI NativeTo solve our Nation's most challenging security problems with cutting-edge AI/ML solutions and products.
Est 2020|Raised $3.7M
Published Sep 26, 2026
| Starting price | Not publicly listed; custom pricing likely | Typically enterprise/custom pricing | Public starting tiers exist; enterprise healthcare usually customized |
| Primary use case | Organizations seeking a partner to apply ML to specific bioscience/security problems with custom algorithms | Organizations running genomics workflows and regulated genomics data operations | Organizations building an end-to-end lakehouse + ML platform with a broad ecosystem |
| Key strength | Domain-focused approach spanning bioscience and certain operational domains; small-vendor flexibility | Genomics-focused platform maturity and ecosystem | Scale, tooling breadth, portability, and platform ecosystem |
| Key limitation | Limited public proof points (documentation, reviews, certifications); unclear repeatability and pricing | May be more specialized than needed for some use cases | Requires internal ML/platform engineering capability |